XML 24 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Fair Value of Financial Instruments
9 Months Ended
Oct. 01, 2011
Fair Value Disclosure [Abstract] 
Fair Value, Measurement Inputs, Disclosure [Text Block]
Fair Value of Financial Instruments (in thousands):

 
Fair value measurements as of October 1, 2011
 
Fair value measurements as of January 1, 2011
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
Short-term marketable securities
$
62,316

 
$
62,316

 
$

 
$

 
$
63,836

 
$
63,836

 
$

 
$

Long-term marketable securities
7,389

 

 

 
7,389

 
10,232

 

 

 
10,232

Foreign currency forward exchange contracts
9

 

 
9

 

 

 

 

 

Total fair value of financial instruments
$
69,714

 
$
62,316

 
$
9

 
$
7,389

 
$
74,068

 
$
63,836

 
$

 
$
10,232


We invest in various financial instruments including corporate and government bonds and notes, commercial paper and auction rate securities. In addition, we enter into foreign currency forward exchange contracts to mitigate our foreign currency exchange rate exposure. The Company carries these instruments at their fair value in accordance with Financial Accounting Standards Board Accounting Standards Codification ("ASC") 820, "Fair Value Measurements and Disclosures" ("ASC 820"). The framework under the provisions of ASC 820 establishes three levels of inputs that may be used to measure fair value. Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

Level 1 instruments generally represent quoted prices in active markets. Therefore, determining fair value for Level 1 instruments generally does not require significant management judgment, and the estimation is not difficult. Our Level 1 instruments consist of federal agency, municipal or corporate notes and bonds that are traded in active markets and are classified as Short-term marketable securities on our Condensed Consolidated Balance Sheet.

Level 2 instruments include inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices for identical instruments in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Our Level 2 instruments include foreign currency forward exchange contracts.

Level 3 instruments include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our auction rate securities are classified as Level 3 instruments. Management uses a combination of the market and the income approach to derive the fair value of auction rate securities, which includes third party valuation results, investment broker provided market information and available information on the credit quality of the underlying collateral. As a result, the determination of fair value for Level 3 instruments requires significant management judgment and subjectivity. Our Level 3 instruments are classified as Long-term marketable securities on our Condensed Consolidated Balance Sheet.

During the nine months ended October 1, 2011 and October 2, 2010, the following changes occurred in our Level 3 instruments (in thousands):
 
 
Nine Months Ended
 
October 1,
2011
 
October 2,
2010
Beginning fair value of Long-term marketable securities
$
10,232

 
$
12,939

Fair value of securities sold or redeemed
(2,843
)
 
(3,220
)
Ending fair value of Long-term marketable securities
$
7,389

 
$
9,719


In accordance with ASC 320, “Investments-Debt and Equity Securities,” the Company recorded an unrealized loss of less than $0.1 million during the nine months ended October 1, 2011 on certain Short-term marketable securities (Level 1 instruments), which has been recorded in Accumulated other comprehensive income. Future fluctuations in fair value related to these instruments that the Company deems to be temporary, including any recoveries of previous write-downs, would be recorded to Accumulated other comprehensive income. In addition, during the nine months ended October 1, 2011, the Company realized a gain of $0.6 million related to the sale of a portion of its Long-term marketable securities portfolio. If the Company were to determine in the future that any further decline in fair value is other-than-temporary, we would record an impairment charge, which could have a materially detrimental impact on our operating results. If we were to liquidate our position in these securities, it is likely that the amount of any future realized gain or loss would be different from the unrealized gain or loss reported in Accumulated other comprehensive income or the previously reported other-than-temporary impairment charge.